微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -0.07% | -109.21% | 99.53% | 98/139 | 1.16% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | -15.02% | -594.08% | -240.59% | 123/139 | 2.07% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | -4.41% | -147.52% | -179.11% | 122/139 | 0.51% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | -1.58% | -120.41% | -307.89% | 114/139 | 1.91% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 0.76% | -86.9% | -75% | 78/139 | 1.04% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 3.04% | -76.93% | -67.24% | 79/139 | 3.02% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 9.28% | -21.36% | 19.9% | 22/139 | 4.75% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 7.74% | -2.4% | 33.45% | 11/139 | 2.98% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 5.8% | 46.1% | -55.99% | 4/139 | 1.65% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 13.18% | 1.07% | 11.69% | 21/139 | 4.92% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 11.8% | 14.67% | 48.8% | 13/139 | 5.8% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 7.93% | 18.89% | 99.75% | 18/139 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 3.97% | 24.45% | -69.56% | 25/139 | 2.28% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 13.04% | 17.69% | 26.72% | 50/139 | 12.93% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 10.29% | 10.17% | 54.27% | 53/139 | 12.7% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 6.67% | 5.21% | 109.09% | 57/139 | 9.24% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 3.19% | -8.07% | -71.21% | 51/139 | 6.21% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 11.08% | -8.58% | 18.63% | 75/139 | 17.28% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 9.34% | -37.23% | 47.32% | 63/139 | 15.82% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 6.34% | -6.49% | 82.71% | 66/139 | 11.46% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 3.47% | 41.06% | -71.37% | 45/139 | 6.18% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 12.12% | -20.73% | -18.55% | 77/139 | 25.47% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 14.88% | 12.47% | 119.47% | 40/139 | 19.63% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 6.78% | -20.33% | 175.61% | 61/139 | 15.03% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 2.46% | -28.28% | -83.91% | 34/139 | 3.37% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 15.29% | 8.21% | 15.57% | 54/139 | 14.24% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 13.23% | 8.8% | 55.46% | 19/139 | 10.37% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 8.51% | 13.47% | 148.1% | 21/139 | 6.65% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 3.43% | 24.73% | -75.73% | 17/139 | 2.68% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 14.13% | 13.49% | 16.2% | 55/139 | 12.87% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 12.16% | 3.23% | 62.13% | 15/139 | 7.11% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 7.5% | 8.85% | 172.73% | 18/139 | 3.2% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 2.75% | 10.89% | -77.91% | 22/139 | 2.61% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 12.45% | 17.12% | 5.69% | 56/139 | 13.76% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 11.78% | 35.09% | 70.97% | 17/139 | 9.4% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 6.89% | 21.73% | 177.82% | 24/139 | 5.88% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 2.48% | 12.22% | -76.67% | 20/139 | 2.65% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 10.63% | 1.24% | 21.9% | 51/139 | 16.11% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 8.72% | 11.22% | 54.06% | 16/139 | 8.66% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 5.66% | 21.2% | 156.11% | 23/139 | 6.24% | *ST明德 | 23.29% | 行业排名> |
| 2016-03-31 | 2.21% | 25.57% | -78.95% | 16/139 | 2.17% | 健帆生物 | 7.75% | 行业排名> |